Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/14/21 19:32 | 9/14/21 | TBIO | Health | BioPrd | Biological Products, (No Diag | Renaud Ronald C Jr | MA | DO | CEO | S.d | -36,254 | 38.00 | 0 | -954 | -100 | 0 | M | ||||||||||||||
9/14/21 19:31 | 4/7/21 | TBIO | Health | BioPrd | Biological Products, (No Diag | Renaud Ronald C Jr | MA | DO | CEO | M.ad | 67 | 7.39 | 0 | 9 | 1 | 954 | D | ||||||||||||||
9/14/21 19:29 | 9/14/21 | TBIO | Health | BioPrd | Biological Products, (No Diag | Burgess Paul D. | MA | OH | COO,CLO | S.d | -2,730 | 38.00 | 0 | -72 | -100 | 0 | D | ||||||||||||||
9/14/21 19:26 | 9/14/21 | TBIO | Health | BioPrd | Biological Products, (No Diag | Hughes Owen | MA | D | S.d | -1,135 | 38.00 | 0 | -30 | -100 | 0 | D | |||||||||||||||
9/14/21 19:23 | 9/14/21 | TBIO | Health | BioPrd | Biological Products, (No Diag | Formela Jean Francois | MA | D | S.d | -78,092 | 38.00 | 0 | -2,055 | -100 | 0 | I | |||||||||||||||
9/14/21 09:59 | 9/14/21 | TBIO | Health | Drug | Pharmaceutical Preparations | Sanofi | I0 | T | P | 2,147,484 | 38.00 | 0 | 71,984 | 999% | 75,668 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |